Antibodies

27 Oct 2008 Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
27 Oct 2008 Progenics Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140
27 Oct 2008 CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
27 Oct 2008 Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
27 Oct 2008 WEHI Spin-Out MuriGen Restructures G-CSF Antagonist Program With CSL
27 Oct 2008 New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
27 Oct 2008 ACZ885 Phase III data show rapid, sustained clinical remission in children and adults suffering from a group of rare, potentially life-threatening autoinflammatory diseases
27 Oct 2008 Data Demonstrate ORENCIA(R) (abatacept) Improves Health-Related Quality of Life, Pain and Sleep Quality in Children With Juvenile Idiopathic Arthritis
25 Oct 2008 New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
24 Oct 2008 Merck KGaA: Erbitux Receives CHMP Positive Opinion for First-Line Use in Head and Neck Cancer
24 Oct 2008 Seattle Genetics Presents Preclinical Data on Antibody-Drug Conjugate Programs
23 Oct 2008 Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment
23 Oct 2008 XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models
21 Oct 2008 Nerviano Medical Sciences Announces a New Collaboration Agreement With Genentech to Discover Antibody Drug Conjugates
21 Oct 2008 Abbott’s HUMIRA(R) (adalimumab) Data Shows Fistula Healing for Up to Three Years in Patients with Moderate to Severe Crohn’s Disease
21 Oct 2008 CytoDyn Files New IND For Cytolin(R)
20 Oct 2008 Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
16 Oct 2008 Lpath Initiates Dosing in Phase 1 Trial for AMD
15 Oct 2008 Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration with Progenics
10 Oct 2008 Biogen Idec Announces Top-Line Results from Phase II Clinical Trial of Baminercept in Rheumatoid Arthritis
10 Oct 2008 Ablynx Provides an R&D Update Announcing it has Successfully Generated Nanobodies(R) Against GPCRs and Presents New Preclinical Development RANKL Programme
07 Oct 2008 Pivotal Phase III study shows MabThera delays disease progression in patients with relapsed or refractory Chronic Lymphocytic Leukaemia
06 Oct 2008 PanGenetics to initiate clinical study of CD40 antagonist antibody in Psoriatic Arthritis
06 Oct 2008 Roche announces topline outcomes for Avastin-Tarceva combination study in advanced lung cancer
06 Oct 2008 New study shows potential benefits of innovative Xolair(R) anti-IgE therapy in treating children suffering from moderate-to-severe allergic asthma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top